The authors incorrectly stated on p. 946 in the Materials and Methods that the Ttll3−/− strain was developed as described by Rocha et al. (2014). However, they actually used two strains, the one described in Rocha et al. (2014) and a new one that was generated by excising exon 6. The corrected text for the first paragraph of the Materials and Methods is as follows.
All wild-type control mice used in our experiments were C57BL/6 mice (Janvier-Europe). For experiments in mice lacking the TTLL3 gene, we used either the Ttll3 mutant mice [European Mouse Mutant Archive (EMMA); mouse strain B6;B6-Ttll3<tm1a(EUCOMM)Wtsi>/Wtsi)] (Rocha et al., 2014), or Ttll3−/− mice. The latter were generated in two steps. First, we excised the lacZ-neomycin cassette in vivo by crossing B6;B6-Ttll3<tm1a(EUCOMM)Wtsi>/Wtsi) mice with a Flp-deleter line (C57BL/6N genetic background FLP under ACTB promoter), generating the Ttll3flox/flox strain. Next, we excised the exon 6 of Ttll3flox/flox mice by crossing them to mice expressing Cre recombinase under the control of a PGK promoter (Lallemand et al., 1998), thus generating the Ttll3−/− strain.
The authors apologise to readers for this error, which does not impact the results or conclusions of the paper. Both the online full text and PDF versions of the article have been corrected.